Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 664-667    DOI: 10.31083/j.ejgo.2020.05.5420
Review | Next articles
Mesonephric-like carcinoma of the uterine corpus: A case report and literature review
Hyang Sook Jeong1, Yuki Gen2, Hui Ryun Joo2, Ji Geun Yoo3, Seung Geun Yeo4, Dong Choon Park2, *()
1Department of Hospital Pathology, St. Vincent's Hospital, The Catholic University of Korea, Seoul, South Korea
2Department of Obstetrics and Gynecology, St. Vincent's Hospital, The Catholic University of Korea, Seoul, South Korea
3Department of Obstetrics and Gynecology, Daejeon St, Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
4Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University, Seoul, South Korea
Download:  PDF(3961KB)  ( 247 ) Full text   ( 31 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
This report describes a woman with uterine mesonephric-like carcinoma and reviews the literature on this rare condition. A 60-year-old woman was referred for abdominal discomfort. Pelvic magnetic resonance imaging showed a tumor, about 7.0 cm in diameter in her left ovary. Surgical exploration, however, showed that both ovaries were grossly free of tumor. Rather, a protruding cancerous mass was found on the left side of her uterus. The tumor was composed of cells with various growth patterns and was diffusely positive for PAX8 and GATA3 on immunohistochemistry. The apical luminal border of the glandular structures was positive for CD10, and the glandular structures were focally positive for EMA. The final diagnosis was mesonephric-like carcinoma, stage pT3N1M. Conclusion: Diagnosing mesonephric-like carcinoma is pathologically challenging because these tumors are rare and present with a wide spectrum of morphologic patterns. Positive staining for PAX8 and GATA3 and a luminal staining pattern of CD10 can support the diagnosis.
Key words:  Mesonephric-like carcinoma      Uterine corpus      Immunohistochemistry     
Submitted:  29 October 2019      Accepted:  27 April 2020      Published:  15 October 2020     
Fund: 
NRF 2017R1D1A1B3030021/National Research Foundation of Korea
NRF 2019R1A2C1086807/National Research Foundation of Korea
*Corresponding Author(s):  DONG CHOON PARK     E-mail:  park.dongchoon@gmail.com

Cite this article: 

Hyang Sook Jeong, Yuki Gen, Hui Ryun Joo, Ji Geun Yoo, Seung Geun Yeo, Dong Choon Park. Mesonephric-like carcinoma of the uterine corpus: A case report and literature review. European Journal of Gynaecological Oncology, 2020, 41(5): 664-667.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.5420     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/664

[1] Jaudah Al-Maghrabi, Haneen Al-Maghrabi. SIRT1 is overexpressed in endometrial adenocarcinoma: a tissue microarray analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 699-704.
[2] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[3] Soo-Young Lee, Dae-Hyung Lee. Perivascular epithelioid cell tumor arising in the left parametrium: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 657-660.
[4] Sung-Im Do, Hee-Chul Shin, Hee Sung Kim. Clinical significance of MET receptor protein and mRNA expression in invasive breast cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 240-245.
[5] Y. S. Lee, J. M. Baek, E. K. Park, C. J. Kim, H. J. Lee, J. O. Kim. Expression and therapeutic potential of macrophage migration inhibitory factor and CD74 in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 65-69.
[6] M.H. Hajeer, A. Al Khader, N.A. Shahin, M.S. Bata. Negative p53 expression and negative high risk HPV in a 26-year-old lady with vulvar keratinizing squamous cell carcinoma: report of a case[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 130-133.
[7] N. K. Šuster, M. Meznaric, N. Škorja, I. Virant-Klun, I. Verdenik, Š. Smrkolj. Cancer stem cell-related marker NANOG expression in ovarian serous tumors using Western blotting and immunohistochemistry: comparison of two techniques[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 948-952.
[8] T. Ishiguro, T. Hatase, K. Nishino, C. Godo, N. Nishikawa, H. Umezu, T. Motoyama, T. Fukuchi, T. Enomoto. Cancer-associated retinopathy in a patient with synchronous fallopian tubal and uterine corpus cancers[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1076-1078.
[9] Yangyang Shi, Yongyun Shi, Dabao Wu. A case of placental site trophoblastic tumor and a retrospective analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1096-1099.
[10] H. Ibrahim, K. Dresser, K. M. Cornejo. Loss of 5-hydroxymethylcytosine (5-hmC) expression in endometrioid type endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 846-848.
[11] A.M. Sindiani, M.S. Alorjani, B.K. Aldaraiseh. Dysgerminoma of the ovary in an adolescent girl associated with a high serum β-human chorionic gonadotropin (β-hCG) level[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 859-861.
[12] S. Kabukcuoglu, B. Hayit. Histopathologic features of advanced stage endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 614-618.
[13] Lan Zhong, Feng Deng, Xingsheng Shu, Zhilan Peng. P53 overexpression predicts unfavorable prognosis of low risk endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 463-467.
[14] H. Cao, S. Yang, S. Xie, M. Xi. The association between p16INK4a and prognosis in endometrial carcinoma: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 311-317.
[15] Xiang Wang, Zhuo Deng, Lijie Wang, He Chen, Huilian Hou, Xu Li. Immunohistochemical analysis of IQGAP2 in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 74-79.
No Suggested Reading articles found!